Q2 STOCKS TO BUY

Analyst Upgrades: Facebook Inc, Twitter Inc, and BioMarin Pharmaceutical Inc.

Analysts upwardly revised their ratings on Facebook Inc (NASDAQ:FB), Twitter Inc (NYSE:TWTR), and BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Oct 2, 2015 at 9:12 AM
facebook X logo linkedin


Analysts are weighing in on social media giants Facebook Inc (NASDAQ:FB) and Twitter Inc (NYSE:TWTR), as well as biotech BioMarin Pharmaceutical Inc. (NASDAQ:BMRN). Here's a quick roundup of today's bullish brokerage notes on FB, TWTR, and BMRN.

  • After yesterday's close, Wedbush initiated coverage on FB with an "outperform" rating and a $115 price target -- which would mark all-time-high territory for the shares. Since peaking at $99.24 on July 21, the stock has been churning, with the $95 area acting as resistance. In the meantime, short sellers have stepped in, with short interest on Facebook Inc increasing by almost 48% during the two most recent reporting periods. If bears continue to target the shares, FB could face headwinds going forward. The security settled at $90.95 on Thursday, and is down 2% in pre-market trading.  

  • Wedbush also weighed in on sector peer TWTR last evening, starting the stock with a "neutral" rating and $30 price target. Recently, the security has struggled, as the Street awaits the company's next CEO. Looking at the charts, Twitter Inc has underperformed the S&P 500 Index (SPX) by more than 17 percentage points in the past three months, touching an all-time low of $21.01 on Aug. 24, and settling yesterday at $24.68. Now it appears the equity's 10-week moving average could continue to apply pressure in the near term, as the shares topped out right at this level earlier in the week. This trendline has been ushering the shares lower since early May.

  • BMRN is 8.5% lower ahead of the open, despite a price-target hike to $157 from $148 at Raymond James. This echoes yesterday's late-afternoon action from Nomura, which boosted its target price for BMRN amid news the company re-acquired the rights for a genetic disorder drug from Germany's Merck KGaA. Both levels mark significant upside to BioMarin Pharmaceutical Inc.'s Thursday close at $109.79, but the stock is a long-term outperformer, gaining 21.4% in 2015. This may be why options traders have been so bullish. BMRN's 10-day International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) call/put volume ratio stands at 4.43 -- higher than two-thirds of all readings from the past year. 

Get the skinny on all the biggest stories of the morning… Sign up now to get Schaeffer's Midday Market Check delivered straight to your inbox!
 
 

“Buy This Stock Now!” - Expert Who Called 11x On TSLA

He called a rare 11x on Tesla…

But now, thanks to Elon & Trump’s new alliance…

He says there’s a new opportunity that could be 1,000x BIGGER than Tesla – and it could completely revolutionize a $23 Trillion market.

It’s trading for less than $5 per share right now…

But it won’t be under the radar for long.

Discover The 1,000x Bigger Elon Opportunity Here

GRAND SLAM COUNTDOWN

 
 

Featured Articles from Trusted Partners:

👀Learn How Dividends Create Passive Income for Life
Receive $200 Off Motley Fool Epic. The Motley Fool Epic $299 discounted offer is based on $499/year list price. Introductory promotion for new members only. Take control of your money and your portfolio with Motley Fool Epic.

💵New Income System Could Pay You $4,243 Monthly
You could collect an average of $4,243 per month starting as early as next week with a new payout system for income investors. New registrations are being accepted for investors who want to be in a position to start with their first payout next week.

🚀Easy 92% Crypto Dividends (No Coins Required)
COIN stock doesn't pay a dividend... But there's actually a new way to collect a massive dividend that's indirectly based on the stock and offers a terrific monthly income (currently yielding nearly 92% on a forward basis).

🤝Free Advisor Match with Wiseradvisor.com
Don't leave your retirement to chance! Get matched with a trusted financial expert for FREE and make the most of your tax refund. Get started now.

⚠️Dennis Quaid's #1 Warning for Americans
Here's the thing: life doesn't come with guarantees. The economy shifts, markets stumble, and years of hard work could slip through your fingers like sand. But it doesn't have to be that way for you. So request a free copy of this Gold & Silver Guide that will arrive right to your doorstep when you act now.

 

 
 

Follow us on X, Follow us on Twitter